Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Deutsche Bank Maintains Hold Rating for Zoom Video Comms: Here's What You Need To Know

Deutsche Bank has decided to maintain its Hold rating of Zoom Video Comms (NASDAQ:ZM) and lower its price target from $155.00 to $105.00. Shares of Zoom Video Comms are trading up 5.68% over the last 24 hours, at $94.40 per share.

Benzinga

Benchmark Maintains Buy Rating for Zoom Video Comms: Here's What You Need To Know

Benchmark has decided to maintain its Buy rating of Zoom Video Comms (NASDAQ:ZM) and raise its price target from $124.00 to $128.00. Shares of Zoom Video Comms are trading up 5.68% over the last 24 hours, at $94.40 per share.

Benzinga

Looking Into Zoom Video Comms's Recent Short Interest

Zoom Video Comms's (NASDAQ:ZM) short percent of float has fallen 10.27% since its last report. The company recently reported that it has 9.81 million shares sold short, which is 4.72% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

50 Stocks Moving In Tuesday's Mid-Day Session

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Benzinga

Goldman Sachs Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of Apellis Pharmaceuticals (NASDAQ:APLS) and lower its price target from $94.00 to $84.00. Shares of Apellis Pharmaceuticals are trading down 2.3% over the last 24 hours, at $43.40 per share.

Benzinga

Preview: Change Healthcare's Earnings

Change Healthcare (NASDAQ:CHNG) is set to give its latest quarterly earnings report on Wednesday, 2022-05-25. Here's what investors need to know before the announcement. Analysts estimate that Change Healthcare will report an earnings per share (EPS) of $0.41.

Benzinga

4 Analysts Have This to Say About Iovance Biotherapeutics

Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Marathon Digital Holdings's Recent Short Interest

Marathon Digital Holdings's (NASDAQ:MARA) short percent of float has risen 9.83% since its last report. The company recently reported that it has 18.77 million shares sold short, which is 20.12% of all regular shares that are available for trading.

Benzinga

Apple Watch With Pride Bands Could Hit Stores This Week

Apple Inc (NASDAQ: AAPL) could release pride editions of Watch bands soon, according to Mark Gurman. What Happened: The tech-focused journalist said on Twitter that the new pride version of the Apple Watch is due for an imminent launch.

Benzinga

As Apple Continues In This Trend, Here's How To Play It Bull And Bear

Apple Inc (NASDAQ: AAPL) opened lower on Tuesday after spiking up 3.86% on Monday in a relief bounce that led the S&P 500 to 1.39% higher.

Benzinga

$100 Invested In Palo Alto Networks 5 Years Ago Would Be Worth This Much

Palo Alto Networks (NASDAQ:PANW) has outperformed the market over the past 5 years by 22.56% on an annualized basis producing an average annual return of 32.51%. Currently, Palo Alto Networks has a market capitalization of $47.62 billion.

Benzinga

Analyst Ratings for Karuna Therapeutics

Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings within the last quarter:

Benzinga

8 Analysts Have This to Say About Sage Therapeutics

Analysts have provided the following ratings for Sage Therapeutics (NASDAQ:SAGE) within the last quarter:

Benzinga

Expert Ratings for United Therapeutics

Within the last quarter, United Therapeutics (NASDAQ:UTHR) has observed the following analyst ratings:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Ricky Gervais' Netflix Special Generates Controversy Over Trans Jokes

For the second time within a year, Netflix Inc (NASDAQ: NFLX) has generated controversy with a comedy special poking fun at the transgender community — and this time, the center of agitation is British funnyman Ricky Gervais.

Benzinga

What 7 Analyst Ratings Have To Say About Dollar Tree

Analysts have provided the following ratings for Dollar Tree (NASDAQ:DLTR) within the last quarter:

Benzinga

BCLI: Anticipating News on How NurOwn® Will be Advanced Forward…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT

Benzinga

If You Invested $1000 In Marathon Digital Holdings 5 Years Ago, Here's How Much You Would Have Today

Marathon Digital Holdings (NASDAQ:MARA) has outperformed the market over the past 5 years by 7.87% on an annualized basis producing an average annual return of 17.84%. Currently, Marathon Digital Holdings has a market capitalization of $958.90 million.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

5 Short Squeeze Candidates To Watch This Week: 2 Former SPACs Join Leaderboard With BigBear.AI Topping List

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

Benzinga

Short Volatility Alert: Altitude Acquisition Corp

On Modnay, shares of Altitude Acquisition Corp. (NASDAQ: ALTU) experienced volatile short activity. After the activity, the stock price went up +0.10% to $9.98. The overall sentiment for ALTU has been Bullish.

Benzinga

Short Volatility Alert: Immunome, Inc.

On Modnay, shares of Immunome, Inc. (NASDAQ: IMNM) experienced volatile short activity. After the activity, the stock price went up +0.30% to $3.31. The overall sentiment for IMNM has been Bearish.

Benzinga

Short Volatility Alert: Catalyst Biosciences

On Modnay, shares of Catalyst Biosciences, Inc. (NASDAQ: CBIO) experienced volatile short activity. After the activity, the stock price went up +234.21% to $1.27. The overall sentiment for CBIO has been Bearish.

Benzinga

Short Volatility Alert: GeoVax Labs

On Modnay, shares of GeoVax Labs, Inc. (NASDAQ: GOVX) experienced volatile short activity. After the activity, the stock price went up +66.91% to $2.32. The overall sentiment for GOVX has been Bearish.

Benzinga

This Foreboding Sign Looms Over Expedia Group's Chart

If history is any guide, there may be trouble ahead for shares of Expedia Group (NASDAQ:EXPE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Marine Petroleum Trust's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from Marine Petroleum Trust (NASDAQ:MARPS).

1 … 493 494 495 496

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.